Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

NCT02136927 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.

NCT NCT02136927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02136927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer
Lead sponsor
Sun Pharma Advanced Research Company Limited
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2014
Completion date
April 30, 2016
Enrollment
33 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer